Angiotensin receptors in vascular tissue.
The biologic effect of angiotensin II is triggered by its interaction with components of target organs, which specifically recognize the hormone. These receptors have been studied with the use of radioactive angiotensin and, as for other peptidic hormones, have been localized in the plasma membrane of target cells. Such angiotensin  receptors have been characterized in three target organs: vascular tissue, uterus and adrenal cortex. The binding characteristics differ in contractile tissue and in adrenal glands, the N and C terminal ends of angiotensin being involved in the former, whereas the N terminus does not appear to have the same importance in the latter. Numerous factors, including ionic composition, seem to be able to modify angiotensin-receptor interaction in vascular smooth muscle. However, the molecular mechanisms responsible for angiotensin binding and for the transmission of the signal determined by receptor-angiotensin interaction are not yet understood. As observed with other peptidic hormones, the number of angiotensin receptors seems to be susceptible to variation under certain conditions. In uterine smooth muscle, it was shown that the number of receptors increased after nephrectomy, a phenomenon which was prevented by the prolonged infusion of angiotensin. The significance of such a variation remains unknown, but it may be partially responsible for the inverse relationship that exists between the endogenous angiotensin level and the pressor effect of exogenous angiotensin. In the near future, investigation of the angiotensin-receptor mechanism will probably answer whether the variation in angiotensin receptors is similar in all target tissues and whether an angiotensin-receptor mechanism is involved in the pathogenesis of certain varieties of hypertension. In addition, a precise understanding of the angiotensin-receptor interaction with help the development of new angiotensin antagonists.
D000302:Adrenal Cortex / Q000032:analysis; D000804:Angiotensin II / Q000378:metabolism / Q000502:physiology; D000818:Animals; D001011:Aorta / Q000032:analysis; D001665:Binding Sites; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000032:analysis* / Q000187:drug effects / Q000648:ultrastructure; D002462:Cell Membrane / Q000032:analysis; D005260:Female; D066298:In Vitro Techniques; D009215:Myometrium / Q000032:analysis; D009392:Nephrectomy; D011817:Rabbits; D051381:Rats; D011945:Receptors, Angiotensin / Q000032:analysis / Q000378:metabolism; D011956:Receptors, Cell Surface
D011945:Receptors, Angiotensin; D011956:Receptors, Cell Surface; D000804:Angiotensin II